Related Experiment Video

Updated: May 24, 2026

Grade III Varicocele Surgical Treatment using Spermatic Vein-Superficial Abdominal Vein Shunt

Grade III Varicocele Surgical Treatment using Spermatic Vein-Superficial Abdominal Vein Shunt

Published on: August 23, 2024

[A patient with bilateral testicular cancer]

S Siebren Dijkstra¹, J A Fred Witjes

¹Radboud Universitair Medisch Centrum, afd. Urologie, Nijmegen, the Netherlands. s.dijkstra@uro.umcn.nl

Nederlands Tijdschrift Voor Geneeskunde

|March 15, 2012

Abstract

Background:

In men aged 15-34 testicular cancer is the most commonly occurring malignancy. After treatment, the average 5-year survival rate is 85%. Recurring symptoms or raised tumour markers may indicate the presence of a second primary contralateral testicular tumour.

Case Description:

A 34-year-old man presented with pain in his left testicle. Eight years previously he had been diagnosed with cancer of his right testicle which was treated successfully by orchidectomy and two cycles of chemotherapy. Further investigations revealed raised tumour markers. The patient proved to have a contralateral testis carcinoma with 2 lung metastases.

Conclusion:

1-3% of patients with testicular cancer develop metachronous (i.e. not concurrent) contralateral testicular cancer. Follow-up and self-examination are very important for early diagnosis of a metachronous contralateral malignancy.

Related Concept Videos

Disorders of the Male Reproductive System

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Articles linked to this work by shared authors, journal, and citation graph.

[Guideline on urothelial carcinoma of the bladder].

Nederlands tijdschrift voor geneeskunde·2010

See all related articles